| Título : |
COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature |
| Tipo de documento : |
documento electrónico |
| Autores : |
Juan Carlos Restrepo Gutiérrez, |
| Fecha de publicación : |
2022 |
| Títulos uniformes : |
Journal of Translational Autoimmunity
|
| Idioma : |
Inglés (eng) |
| Palabras clave : |
Autoimmune hepatitis COVID-19 SARS-CoV-2 AstraZeneca ChAdOx1 nCoV-19 AZD1222 |
| Resumen : |
Autoimmunity following COVID-19 vaccination has been reported. Herein, a 79-year-old man with clinical and immunological features of autoimmune hepatitis type 1 after ChAdOx1 nCoV-19 vaccination is presented. Clinical manifestations rapidly remitted after the instauration of immunomodulatory management. This case, together with a comprehensive review of the literature, illustrates the association between COVID-19 vaccines and the development of autoimmune conditions. |
| Mención de responsabilidad : |
Laura Camacho-Domínguez, Yhojan Rodríguez, Fernando Polo, Juan Carlos Restrepo Gutierrez, Elizabeth Zapata, Manuel Rojas, Juan-Manuel Anaya |
| Referencia : |
J Transl Autoimmun. 2022;5:100140. |
| DOI (Digital Object Identifier) : |
10.1016/j.jtauto.2022.100140 |
| PMID : |
35013724 |
| Derechos de uso : |
CC BY-NC-ND |
| En línea : |
https://linkinghub.elsevier.com/retrieve/pii/S2589909022000016 |
| Enlace permanente : |
https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis |
COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature [documento electrónico] / Juan Carlos Restrepo Gutiérrez, . - 2022. Obra : Journal of Translational AutoimmunityIdioma : Inglés ( eng)
| Palabras clave : |
Autoimmune hepatitis COVID-19 SARS-CoV-2 AstraZeneca ChAdOx1 nCoV-19 AZD1222 |
| Resumen : |
Autoimmunity following COVID-19 vaccination has been reported. Herein, a 79-year-old man with clinical and immunological features of autoimmune hepatitis type 1 after ChAdOx1 nCoV-19 vaccination is presented. Clinical manifestations rapidly remitted after the instauration of immunomodulatory management. This case, together with a comprehensive review of the literature, illustrates the association between COVID-19 vaccines and the development of autoimmune conditions. |
| Mención de responsabilidad : |
Laura Camacho-Domínguez, Yhojan Rodríguez, Fernando Polo, Juan Carlos Restrepo Gutierrez, Elizabeth Zapata, Manuel Rojas, Juan-Manuel Anaya |
| Referencia : |
J Transl Autoimmun. 2022;5:100140. |
| DOI (Digital Object Identifier) : |
10.1016/j.jtauto.2022.100140 |
| PMID : |
35013724 |
| Derechos de uso : |
CC BY-NC-ND |
| En línea : |
https://linkinghub.elsevier.com/retrieve/pii/S2589909022000016 |
| Enlace permanente : |
https://hospitalpablotobon.cloudbiteca.com/pmb/opac_css/index.php?lvl=notice_dis |
|  |